| Financial Year |
March 31 2023 |
| Monetary Funds |
467,221,229.59 |
| Held-for-trading Financial Assets |
390,625,660.00 |
| Notes Receivable |
651,981.00 |
| Accounts Receivable |
680,083,157.61 |
| Advances to Suppliers |
120,426,075.41 |
| Other Receivables |
33,210,136.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
774,947,519.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,854,544.96 |
| Total Current Assets |
2,519,708,855.56 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
45,894,522.40 |
| Investment Properties |
11,011,380.65 |
| Fixed Assetes |
545,850,722.07 |
| Under-construction Projects |
576,250,173.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
176,188,708.54 |
| R&D expenses |
-- |
| Goodwill |
18,502,240.81 |
| Long-Term Deferred and Prepaid Expenses |
15,077,846.76 |
| Deferred Income Tax Assets |
21,837,057.05 |
| Other Non-Current Assets |
71,343,426.92 |
| Sub-Total of Non-Current Assets |
1,530,227,424.06 |
| Total Assets |
4,049,936,279.62 |
| Short-Term Loans |
350,910,565.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,680,212.16 |
| Accounts Payable |
202,693,545.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
21,676,174.31 |
| Taxes Payable |
31,134,818.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
16,095,560.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,821,755.43 |
| Other Current Liabilities |
5,903,246.46 |
| Sub-Total of Current Liabilities |
795,865,039.88 |
| Long-term Loans |
502,528,280.04 |
| Bonds Payable |
227,249,865.86 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
95,838,293.10 |
| Sub-Total of Non-Current Liabilities |
842,129,964.58 |
| Total Liabilities |
1,637,995,004.46 |
| Paid-In Capital(Or Share Stock) |
626,551,245.00 |
| Capital Surplus |
1,042,441,662.60 |
| Surplus Reserve |
141,384,660.63 |
| LESS:Treasury Stock |
81,312,639.01 |
| Undistributed Profits |
575,737,398.71 |
| Minority Stockholder's Interest |
54,626,954.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,357,314,320.77 |
| Owner's Equity（Stockholder's Equity） |
2,411,941,275.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,049,936,279.62 |
